Related Experiment Video
Updated: Dec 21, 2025
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.0K
Venous Thromboembolism During Chemotherapy for Testicular Cancer: A Population-Based Study
A G Robinson1, X Wei2, S Karim3
1Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, Canada; Departments of Oncology, Queen's University, Kingston, Canada.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|May 11, 2020
Summary
Germ cell cancer patients receiving chemotherapy have a high risk of venous thromboembolism (VTE). The risk increases with more chemotherapy cycles, highlighting the need for preventative strategies.
Area of Science:
- Oncology
- Hematology
- Clinical Epidemiology
Background:
- Venous thromboembolism (VTE) is a significant complication for germ cell tumor (GCT) patients.
- Understanding VTE incidence and risk factors in GCT patients is crucial for clinical management.
Purpose of the Study:
- To evaluate the incidence rate, timing, and associated factors of VTE in GCT patients in a real-world setting.
- To identify patient, disease, and treatment-related factors influencing VTE risk.
Main Methods:
- A population-based cohort study using the Ontario Cancer Registry linked to treatment records (2000-2010).
- Identification of testicular cancer patients undergoing orchiectomy and VTE events within specified timeframes.
- Exploration of factors associated with VTE, including chemotherapy details.
Main Results:
- The VTE rate was 8% in chemotherapy recipients versus 0.6% in non-recipients.
- VTE commonly occurred within the first three months after initiating chemotherapy.
- An increasing number of chemotherapy cycles was independently associated with a higher VTE risk.
Conclusions:
- This study confirms a high VTE rate in GCT patients treated with chemotherapy.
- Further research into VTE prophylactic strategies is warranted to mitigate this risk.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
215
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
215
01:29Venous Thrombosis III: Interprofessional Care
209
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
209
01:30Venous Thrombosis I: Introduction
189
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
189
01:30Venous Thrombosis IV: Nursing Management
148
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
148
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
187
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
187